Refractory kaposiform lymphangiomatosis relieved by splenectomy [PDF]
IntroductionKaposiform lymphangiomatosis (KLA) is a rare and complex lymphatic anomaly with a poor prognosis. There is no standard treatment, and drug therapies are the most common therapeutic method.
Yuru Lan +4 more
doaj +4 more sources
Sirolimus in the treatment of kaposiform lymphangiomatosis [PDF]
Background Kaposiform lymphangiomatosis (KLA), which is a new subtype of generalized lymphatic anomaly, is a rare disease with a poor prognosis. Currently, there is no standard treatment due to the poor understanding of KLA.
Jiangyuan Zhou +3 more
doaj +5 more sources
Kaposiform lymphangiomatosis and kaposiform hemangioendothelioma: similarities and differences [PDF]
Background Kaposiform lymphangiomatosis (KLA) and kaposiform hemangioendothelioma (KHE) are rare and aggressive vascular disorders. The aim of this study was to examine the clinical features and prognosis of KLA and KHE involving the thorax.
Yi Ji +4 more
doaj +5 more sources
Kaposiform lymphangiomatosis effectively treated with MEK inhibition [PDF]
Kaposiform lymphangiomatosis (KLA) is a rare lymphatic anomaly primarily affecting the mediastinum with high mortality rate. We present a patient with KLA and significant disease burden harboring a somatic point mutation in the Casitas B lineage lymphoma
Jessica B Foster +6 more
doaj +4 more sources
Kaposiform Lymphangiomatosis in a Male Adolescent: A Clinical Challenge and the Role of Genetics [PDF]
Kaposiform lymphangiomatosis (KLA) is a rare and aggressive generalized lymphatic anomaly (GLA), with distinctive clinical, radiology, morphologic, and genetic features.
Joana Pereira-Nunes MD +5 more
doaj +4 more sources
Challenging diagnosis of Kaposiform lymphangiomatosis: Unveiling a rare primary lymphatic disorder [PDF]
Kaposiform lymphangiomatosis (KLA) is a rare and complex lymphatic anomaly associated with substantial morbidity and mortality. It features diffuse and multifocal malformed lymphatic channels, often leading to diagnostic difficulties due to its uncommon ...
Rafael Ospino, BS, Claire Brookmeyer, MD
doaj +4 more sources
Kaposiform lymphangiomatosis: Diagnosis, pathogenesis, and treatment. [PDF]
AbstractKaposiform lymphangiomatosis (KLA) is a life‐threatening rare disease that can cause substantial morbidity, mortality, and social burdens for patients and their families. Diagnosis often occurs long after initial symptoms, and there are few centers in the world with the expertise to diagnose and care for patients with the disease.
McDaniel CG +8 more
europepmc +3 more sources
Kaposiform Lymphangiomatosis: Pathologic Aspects in 43 Patients. [PDF]
Kaposiform lymphangiomatosis is an uncommon generalized lymphatic anomaly with distinctive clinical, radiologic, histopathologic, and molecular findings. Herein, we document the pathology in 43 patients evaluated by the Boston Children’s Hospital Vascular Anomalies Center from 1999 to 2020.
Perez-Atayde AR +19 more
europepmc +3 more sources
Kaposiform lymphangiomatosis presenting with a Group A Streptococcus pericardial effusion. [PDF]
A 4-year-old child was transferred to the paediatric intensive care unit with acute respiratory failure following 4 days of fever, nausea and vomiting. Chest X-ray on admission had an enlarged cardiac silhouette and transthoracic echo confirmed a large pericardial effusion.
Koerner T +3 more
europepmc +4 more sources
Treatment of severe Kaposiform lymphangiomatosis positive for NRAS mutation by MEK inhibition. [PDF]
Kaposiform lymphangiomatosis (KLA) is a complex lymphatic anomaly involving most commonly the mediastinum, lung, skin and bones with few effective treatments. In recent years, RAS-MAPK pathway mutations were shown to underlie the pathogenesis of several complex lymphatic anomalies.
Chowers G +14 more
europepmc +3 more sources

